MedPath

Glutathione

Generic Name
Glutathione
Drug Type
Small Molecule
Chemical Formula
C10H17N3O6S
CAS Number
70-18-8
Unique Ingredient Identifier
GAN16C9B8O

Overview

A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides.

Indication

For nutritional supplementation, also for treating dietary shortage or imbalance

Associated Conditions

  • Hangover
  • Nerve Disorders
  • Neuropathy

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/04/10
Not Applicable
Recruiting
General Hospital of Shenyang Military Region
2025/03/26
Phase 1
Recruiting
The First Affiliated Hospital of Zhengzhou University
2023/07/20
Phase 4
Terminated
2019/09/26
Phase 1
Completed
Dr Irma Bernadette S Sitohang
2017/01/13
Phase 2
Completed
2016/07/28
Phase 1
UNKNOWN
South Florida Veterans Affairs Foundation for Research and Education
2015/10/22
Phase 3
Completed
Robert J. Porte
2015/04/23
Phase 2
Completed
2014/12/24
Phase 1
Completed
2014/12/09
Phase 3
Completed

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
The Wellness Center for Research and Education, Inc.
50181-0031
ORAL
6 [hp_X] in 1 mL
5/28/2025

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
ESSENTIALS PLUS - TAB
alive international
02229851
Tablet - Oral
0.5 MG
1/28/1997

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.